There is a debate and it is hot too, the question is Covid19 mRNA vaccines and heart inflammation related?
Amidst increasing controversies surrounding the rise of blood clots with the AstraZeneca vaccine, named Covishield in India, Johnson and Johnson’s Jannsen vaccine, and reports of the Pfizer shot putting younger men at a heightened risk of myocarditis were witnessed in Israel recently and their country’s health ministry launched investigations to get further details on blood clotting.
Researchers also observed that symptoms of myocarditis and pericarditis, after vaccination were mostly reported in countries which are administering mRNA vaccine, deaths mostly recorded in men younger than 30 and younger women.
Myocarditis refers to the condition which is caused when the middle layer of the heart gets inflamed, due to severe infection, symptoms such as erratic heartbeat due to possible problems like disrupted oxygenated blood flow, pain, weakening of muscles and heart walls that can weaken the heart’s electrical system, lead to heart failure, and in some cases, even sudden death.
Now many country’s which are administering mRNA vaccine, advise their citizen to keep a watch on their heart beats, and even requesting the COVID recovered patients to get their heart checked up and be on the lookout for possible complications time to time.
In India out of the 24,703 cases (or 94% of the total AEFI cases) were linked to Covishield
Earlier in a data released In India in June 2021 out of the 24,703 cases (or 94% of the total AEFI cases) were linked to Covishield. To be sure, this is in context of the shots administered overall. Twenty-one crore doses of Covishield were used between January 16 — the day COVID-19 vaccinations began in India — and June 7
Earlier on Wednesday The U.S. Food and Drug Administration said it plans to move quickly to add a warning about rare cases of heart inflammation in adolescents and young adults to fact sheets for the Pfizer/BioNTech (PFE.N), and Moderna (MRNA.O) COVID-19 vaccines.
U.S. Centers for Disease Control and Prevention (CDC) advisory groups, meeting to discuss reported cases of the heart condition after vaccination, found the inflammation in adolescents and young adults is likely linked to the vaccines, but that the benefits of the shots appeared to clearly outweigh the risk.
Doctors and hospitals have been warned by the CDC to watch for symptoms of myocarditis or pericarditis, and the FDA warning will further raise awareness.
Concerns about the more highly transmissible Delta coronavirus variant taking hold in the United States, and its impact on younger people, have added to the urgency to increase vaccinations even as the inoculation effort here has slowed considerably
